Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

PubWeight™: 5.33‹?› | Rank: Top 1%

🔗 View Article (PMID 12824208)

Published in JAMA on June 25, 2003

Authors

Holly J Kramer1, Quan Dong Nguyen, Gary Curhan, Chi-Yuan Hsu

Author Affiliations

1: Department of Preventive Medicine, Division of Nephrology, Loyola University Medical Center, Maywood, IL 60153, USA. hkramer@lumc.edu

Associated clinical trials:

Non Diabetic Causes of Chronic Kidney Disease in Type 2 Diabetic Patients | NCT05021705

Articles citing this

(truncated to the top 100)

Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85

Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28

Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94

Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66

Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78

Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70

Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05

Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol (2010) 3.12

Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res (2006) 2.61

Defining incident chronic kidney disease in the research setting: The ARIC Study. Am J Epidemiol (2009) 2.22

In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2010) 2.22

Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care (2010) 2.08

Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney Int (2011) 1.91

Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care (2012) 1.85

New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79

Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care (2009) 1.74

Cerebral microvascular disease predicts renal failure in type 2 diabetes. J Am Soc Nephrol (2010) 1.72

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A (2008) 1.70

Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia (2014) 1.55

Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med (2008) 1.52

Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc (2011) 1.43

Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A (2004) 1.38

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37

Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol (2009) 1.19

Haptoglobin genotype and renal function decline in type 1 diabetes. Diabetes (2009) 1.18

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. BMJ Open (2016) 1.16

Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol (2008) 1.11

The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy. Korean J Intern Med (2013) 1.10

Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Diabetes Care (2010) 1.09

Chronic kidney disease screening methods and its implication for Malaysia: an in depth review. Glob J Health Sci (2015) 1.09

Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean Med Sci (2011) 1.08

Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol (2009) 1.06

Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care (2012) 1.06

Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002. J Gen Intern Med (2006) 1.03

Diabetic kidney disease: from epidemiology to clinical perspectives. Diabetes Metab J (2014) 1.03

Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. Diabetes Metab J (2014) 1.02

More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care (2012) 1.00

Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res (2013) 0.96

A story of microalbuminuria and diabetic nephropathy. J Nephropathol (2013) 0.96

Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol (2010) 0.96

Does multimorbidity influence the occurrence rates of chronic conditions? A claims data based comparison of expected and observed prevalence rates. PLoS One (2012) 0.95

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study. Cardiorenal Med (2011) 0.95

Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care (2013) 0.95

Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes. Kidney Int (2013) 0.95

Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes. Diabetes Care (2009) 0.95

Haptoglobin genotype and its role in diabetic cardiovascular disease. J Cardiovasc Transl Res (2012) 0.94

Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care (2012) 0.93

Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Clin J Am Soc Nephrol (2010) 0.91

Variants of GCKR affect both β-cell and kidney function in patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study 2. Diabetes Care (2011) 0.90

The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2013) 0.90

Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area. BMC Nephrol (2012) 0.89

Non-Proteinuric Diabetic Nephropathy. J Clin Med (2015) 0.89

The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. J Korean Med Sci (2009) 0.88

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol (2015) 0.88

Obstructive sleep apnea and diabetic nephropathy: a cohort study. Diabetes Care (2013) 0.88

The association of genetic variants of type 2 diabetes with kidney function. Kidney Int (2012) 0.87

The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study. Am J Physiol Renal Physiol (2011) 0.87

Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease. Diabetes Care (2012) 0.86

Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. Wien Klin Wochenschr (2009) 0.86

Limitations and future treatment options in type 2 diabetes with renal impairment. Diabetes Care (2011) 0.86

Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives. Endocrinol Metab Clin North Am (2013) 0.86

Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best? Drugs Context (2013) 0.86

Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol (2008) 0.85

High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data. Am J Med Sci (2010) 0.85

Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant (2011) 0.85

Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes. Diabetes Care (2012) 0.84

Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency. Clin Exp Nephrol (2013) 0.84

Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications (2012) 0.83

Diabetic nephropathy - Epidemiology in Asia and the current state of treatment. Indian J Nephrol (2011) 0.83

Hypertension-attributed nephropathy: what's in a name? Nat Rev Nephrol (2015) 0.82

Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes. Korean J Intern Med (2009) 0.82

The association of retinopathy and low GFR in type 2 diabetes. Diabetes Res Clin Pract (2012) 0.82

Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade. J Clin Med (2015) 0.82

Prevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 Diabetes. Endocrinol Metab (Seoul) (2016) 0.82

Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials. Rev Diabet Stud (2013) 0.81

Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol (2013) 0.81

The Relationship between Estimated Glomerular Filtration Rate and Diabetic Retinopathy. J Ophthalmol (2015) 0.81

Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2. BMC Med Genet (2013) 0.80

Risks of rapid decline renal function in patients with type 2 diabetes. World J Diabetes (2014) 0.80

Renal Biopsy in Type 2 Diabetic Patients. J Clin Med (2015) 0.80

Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study. PLoS One (2015) 0.80

Differences in risk factors for the onset of albuminuria and decrease in glomerular filtration rate in people with Type 2 diabetes mellitus: implications for the pathogenesis of diabetic kidney disease. Diabet Med (2015) 0.79

Urinary biomarkers for early diabetic nephropathy: beyond albuminuria. Pediatr Nephrol (2014) 0.79

Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus. Kidney Int Suppl (2011) (2012) 0.79

[Diabetic nephropathy--update 2012]. Wien Klin Wochenschr (2012) 0.79

Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes. PLoS One (2016) 0.79

Biomarkers in diabetic nephropathy: Present and future. World J Diabetes (2014) 0.78

Novel urinary biomarkers in pre-diabetic nephropathy. Clin Exp Nephrol (2015) 0.78

Prevalence of reduced renal function among diabetic hypertensive patients. Int J Physiol Pathophysiol Pharmacol (2008) 0.78

Causes of renal failure in patients with type 2 diabetes mellitus. JAMA (2003) 0.78

Subnormal Estimated Glomerular Filtration Rate Strongly Predict Incident Cardiovascular Events in Type 2 Diabetic Chinese Population With Normoalbuminuria. Medicine (Baltimore) (2016) 0.78

Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol (2017) 0.78

Early detection of diabetic kidney disease: Present limitations and future perspectives. World J Diabetes (2016) 0.78

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets. J Diabetes Res (2015) 0.77

Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort study. Sci Rep (2016) 0.77

The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease. Medicine (Baltimore) (2016) 0.77

Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus. Diabetes Metab J (2015) 0.77

Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes? Korean J Intern Med (2013) 0.76

Arterial stiffness and renal impairment in non-proteinuric type 2 diabetic patients. J Diabetes Investig (2012) 0.75

Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus. Medicine (Baltimore) (2015) 0.75

Articles by these authors

(truncated to the top 100)

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology (2012) 8.29

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med (2004) 6.53

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74

Alcohol intake and risk of incident gout in men: a prospective study. Lancet (2004) 4.12

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ (2008) 3.71

Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol (2002) 3.48

Independent impact of gout on mortality and risk for coronary heart disease. Circulation (2007) 3.39

Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr (2010) 3.19

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology (2013) 2.99

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med (2007) 2.89

Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol (2010) 2.86

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ (2006) 2.85

Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med (2005) 2.80

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther (2008) 2.59

Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther (2006) 2.59

Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54

In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43

Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int (2005) 2.43

Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34

The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis (2002) 2.26

Health literacy and access to kidney transplantation. Clin J Am Soc Nephrol (2008) 2.26

Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2005) 2.25

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology (2012) 2.20

High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation (2004) 2.17

Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study. Am J Obstet Gynecol (2003) 2.13

Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension (2007) 2.05

Vitamin C intake and serum uric acid concentration in men. J Rheumatol (2008) 2.05

Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol (2009) 2.02

Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2007) 1.95

Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants. Ophthalmology (2012) 1.95

Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86

Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation (2009) 1.85

Association of sweetened beverage intake with incident hypertension. J Gen Intern Med (2012) 1.81

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation (2004) 1.78

Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet (2011) 1.77

Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72

Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69

The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int (2005) 1.63

Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol (2008) 1.57

Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum (2004) 1.51

Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet (2013) 1.51

Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology (2005) 1.46

Persistent diabetic macular edema is associated with elevated hemoglobin A1c. Am J Ophthalmol (2005) 1.43

Fructose-rich beverages and risk of gout in women. JAMA (2010) 1.42

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med (2003) 1.39

Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol (2011) 1.39

Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36

The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology (2011) 1.34

Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med (2009) 1.33

Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis (2004) 1.30

Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol (2005) 1.28

RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol (2010) 1.27

The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol (2002) 1.25

Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum (2007) 1.24

Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet (2011) 1.23

Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med (2011) 1.20

Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med (2007) 1.20

Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology (2011) 1.18

Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology (2010) 1.13

Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum (2007) 1.13

Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet (2011) 1.10

Measured GFR as "gold standard"--all that glitters is not gold? Clin J Am Soc Nephrol (2011) 1.08

Duration of lactation and incidence of maternal hypertension: a longitudinal cohort study. Am J Epidemiol (2011) 1.08

Wide-field retinal imaging in the management of noninfectious posterior uveitis. Am J Ophthalmol (2012) 1.08

Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect (2012) 1.07

Long-term outcomes after acute kidney injury: where we stand and how we can move forward. Am J Kidney Dis (2009) 1.06

Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury. Curr Opin Nephrol Hypertens (2011) 1.03

FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study. Ann Intensive Care (2011) 1.02

Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol (2013) 1.02

Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol (2005) 1.02

Measurement of oxygen saturation in the retina with a spectroscopic sensitive multi aperture camera. Opt Express (2008) 1.02

Retinal optical coherence tomography manifestations of intraocular lymphoma. J Ophthalmic Inflamm Infect (2012) 1.01

Management of retained subretinal perfluorocarbon liquid. Ophthalmic Surg Lasers Imaging Retina (2013) 0.99

Cystatin C: a marker of renal function or something more? Clin Chem (2005) 0.98

Retina-simulating phantom for optical coherence tomography. J Biomed Opt (2014) 0.97

Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia (2014) 0.97

Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. Ocul Immunol Inflamm (2011) 0.96

Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction. Retina (2007) 0.96

Absolute blood velocity measured with a modified fundus camera. J Biomed Opt (2010) 0.96

Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography. Invest Ophthalmol Vis Sci (2006) 0.96

Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology (2013) 0.96

Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect (2013) 0.95

Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol (2012) 0.95

Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr (2010) 0.94

Optical coherence tomography features of sub-internal limiting membrane hemorrhage and preretinal membrane in Valsalva retinopathy. Can J Ophthalmol (2007) 0.94

Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care (2007) 0.94

Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens (2007) 0.93

Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? Eur Heart J (2005) 0.93

Fluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic management. Int J Nanomedicine (2007) 0.92

New treatment options for noninfectious uveitis. Dev Ophthalmol (2012) 0.92

Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion. Am J Ophthalmol (2013) 0.89

Enterococcus casseliflavus endophthalmitis associated with a horse tail injury. Arch Ophthalmol (2009) 0.89